Cargando…
Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
PURPOSE: While patients with intermediate-risk (IR) Wilms tumors now have an overall survival (OS) rate of almost 90%, those affected by high-stage tumors with diffuse anaplasia have an OS of only around 50%. We here identify key events in the pathogenesis of diffuse anaplasia by mapping cancer cell...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345961/ https://www.ncbi.nlm.nih.gov/pubmed/37140929 http://dx.doi.org/10.1158/1078-0432.CCR-23-0311 |
_version_ | 1785073208098029568 |
---|---|
author | Rastegar, Bahar Andersson, Natalie Petersson, Alexandra Karlsson, Jenny Chattopadhyay, Subhayan Valind, Anders Jansson, Caroline Durand, Geoffroy Romerius, Patrik Jirström, Karin Holmquist Mengelbier, Linda Gisselsson, David |
author_facet | Rastegar, Bahar Andersson, Natalie Petersson, Alexandra Karlsson, Jenny Chattopadhyay, Subhayan Valind, Anders Jansson, Caroline Durand, Geoffroy Romerius, Patrik Jirström, Karin Holmquist Mengelbier, Linda Gisselsson, David |
author_sort | Rastegar, Bahar |
collection | PubMed |
description | PURPOSE: While patients with intermediate-risk (IR) Wilms tumors now have an overall survival (OS) rate of almost 90%, those affected by high-stage tumors with diffuse anaplasia have an OS of only around 50%. We here identify key events in the pathogenesis of diffuse anaplasia by mapping cancer cell evolution over anatomic space in Wilms tumors. EXPERIMENTAL DESIGN: We spatially mapped subclonal landscapes in a retrospective cohort of 20 Wilms tumors using high-resolution copy-number profiling and TP53 mutation analysis followed by clonal deconvolution and phylogenetic reconstruction. Tumor whole-mount sections (WMS) were utilized to characterize the distribution of subclones across anatomically distinct tumor compartments. RESULTS: Compared with non-diffuse anaplasia Wilms tumors, tumors with diffuse anaplasia showed a significantly higher number of genetically distinct tumor cell subpopulations and more complex phylogenetic trees, including high levels of phylogenetic species richness, divergence, and irregularity. All regions with classical anaplasia showed TP53 alterations. TP53 mutations were frequently followed by saltatory evolution and parallel loss of the remaining wild-type (WT) allele in different regions. Morphologic features of anaplasia increased with copy-number aberration (CNA) burden and regressive features. Compartments demarcated by fibrous septae or necrosis/regression were frequently (73%) associated with the emergence of new clonal CNAs, although clonal sweeps were rare within these compartments. CONCLUSIONS: Wilms tumors with diffuse anaplasia display significantly more complex phylogenies compared with non-diffuse anaplasia Wilms tumors, including features of saltatory and parallel evolution. The subclonal landscape of individual tumors was constrained by anatomic compartments, which should be considered when sampling tissue for precision diagnostics. |
format | Online Article Text |
id | pubmed-10345961 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Association for Cancer Research |
record_format | MEDLINE/PubMed |
spelling | pubmed-103459612023-07-15 Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution Rastegar, Bahar Andersson, Natalie Petersson, Alexandra Karlsson, Jenny Chattopadhyay, Subhayan Valind, Anders Jansson, Caroline Durand, Geoffroy Romerius, Patrik Jirström, Karin Holmquist Mengelbier, Linda Gisselsson, David Clin Cancer Res Translational Cancer Mechanisms and Therapy PURPOSE: While patients with intermediate-risk (IR) Wilms tumors now have an overall survival (OS) rate of almost 90%, those affected by high-stage tumors with diffuse anaplasia have an OS of only around 50%. We here identify key events in the pathogenesis of diffuse anaplasia by mapping cancer cell evolution over anatomic space in Wilms tumors. EXPERIMENTAL DESIGN: We spatially mapped subclonal landscapes in a retrospective cohort of 20 Wilms tumors using high-resolution copy-number profiling and TP53 mutation analysis followed by clonal deconvolution and phylogenetic reconstruction. Tumor whole-mount sections (WMS) were utilized to characterize the distribution of subclones across anatomically distinct tumor compartments. RESULTS: Compared with non-diffuse anaplasia Wilms tumors, tumors with diffuse anaplasia showed a significantly higher number of genetically distinct tumor cell subpopulations and more complex phylogenetic trees, including high levels of phylogenetic species richness, divergence, and irregularity. All regions with classical anaplasia showed TP53 alterations. TP53 mutations were frequently followed by saltatory evolution and parallel loss of the remaining wild-type (WT) allele in different regions. Morphologic features of anaplasia increased with copy-number aberration (CNA) burden and regressive features. Compartments demarcated by fibrous septae or necrosis/regression were frequently (73%) associated with the emergence of new clonal CNAs, although clonal sweeps were rare within these compartments. CONCLUSIONS: Wilms tumors with diffuse anaplasia display significantly more complex phylogenies compared with non-diffuse anaplasia Wilms tumors, including features of saltatory and parallel evolution. The subclonal landscape of individual tumors was constrained by anatomic compartments, which should be considered when sampling tissue for precision diagnostics. American Association for Cancer Research 2023-07-14 2023-05-04 /pmc/articles/PMC10345961/ /pubmed/37140929 http://dx.doi.org/10.1158/1078-0432.CCR-23-0311 Text en ©2023 The Authors; Published by the American Association for Cancer Research https://creativecommons.org/licenses/by-nc-nd/4.0/This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license. |
spellingShingle | Translational Cancer Mechanisms and Therapy Rastegar, Bahar Andersson, Natalie Petersson, Alexandra Karlsson, Jenny Chattopadhyay, Subhayan Valind, Anders Jansson, Caroline Durand, Geoffroy Romerius, Patrik Jirström, Karin Holmquist Mengelbier, Linda Gisselsson, David Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution |
title | Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution |
title_full | Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution |
title_fullStr | Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution |
title_full_unstemmed | Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution |
title_short | Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution |
title_sort | resolving the pathogenesis of anaplastic wilms tumors through spatial mapping of cancer cell evolution |
topic | Translational Cancer Mechanisms and Therapy |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345961/ https://www.ncbi.nlm.nih.gov/pubmed/37140929 http://dx.doi.org/10.1158/1078-0432.CCR-23-0311 |
work_keys_str_mv | AT rastegarbahar resolvingthepathogenesisofanaplasticwilmstumorsthroughspatialmappingofcancercellevolution AT anderssonnatalie resolvingthepathogenesisofanaplasticwilmstumorsthroughspatialmappingofcancercellevolution AT peterssonalexandra resolvingthepathogenesisofanaplasticwilmstumorsthroughspatialmappingofcancercellevolution AT karlssonjenny resolvingthepathogenesisofanaplasticwilmstumorsthroughspatialmappingofcancercellevolution AT chattopadhyaysubhayan resolvingthepathogenesisofanaplasticwilmstumorsthroughspatialmappingofcancercellevolution AT valindanders resolvingthepathogenesisofanaplasticwilmstumorsthroughspatialmappingofcancercellevolution AT janssoncaroline resolvingthepathogenesisofanaplasticwilmstumorsthroughspatialmappingofcancercellevolution AT durandgeoffroy resolvingthepathogenesisofanaplasticwilmstumorsthroughspatialmappingofcancercellevolution AT romeriuspatrik resolvingthepathogenesisofanaplasticwilmstumorsthroughspatialmappingofcancercellevolution AT jirstromkarin resolvingthepathogenesisofanaplasticwilmstumorsthroughspatialmappingofcancercellevolution AT holmquistmengelbierlinda resolvingthepathogenesisofanaplasticwilmstumorsthroughspatialmappingofcancercellevolution AT gisselssondavid resolvingthepathogenesisofanaplasticwilmstumorsthroughspatialmappingofcancercellevolution |